Abstract:OBJECTIVE:To evaluate the clinical practical value of apparent diffusion coefficient (ADC) measurements based on diffusion-weighted MR imaging (DWI) for quantification of liver fibrosis and inflammation for hepatitis viral infection. METHODS:Diffusion-weighted MRI with parallel imaging was prospectively performed on 85 patients with chronic hepatitis and on 22 healthy volunteers within a single breath-hold using a single-shot spin-echo echo-planar sequence at b values of 100, 300, 500, 800 and 1000 s/mm2 respectively. ADC values of liver were measured with five different b values. The inflammation grades and fibrosis stages were evaluated histologically by biopsy. One-way analysis of variance and Spearman' s rank correlation test were used for statistical analysis. Receiver operating characteristics analysis was used to assess the performance of ADC in predicting the presence of stage > or = 2 and stage > or = 3 hepatic fibrosis, and grade > or = 1 hepatic inflammation. RESULTS:There was moderate negative correlation between hepatic ADC values and fibrosis stage. And the best correlation was obtained for a b value of 800 s/mm2 (r = -0.697, P = 0. 000). At all b values there was a significant decrease in hepatic ADC in patients with stage < or = 1 versus stage > or = 2 fibrosis and stage < or = 2 versus stage > or = 3 fibrosis (P < 0.05). Hepatic ADC was a significant predictor of stage > or = 2 and > or = 3 fibrosis. The areas under the curve were 0.909 vs 0.917, sensitivity 76.6% vs 80.0% and specificity 88.3% vs 91.5% (ADC with a b value of 800 s/mm2, 1.26 x 10(-3) mm2/s or less and 1.19 x 10(-3) mm2/s or less). There was weak to moderate negative correlation between ADCs and inflammation grade. Hepatic ADC was a significant predictor of grade > 1 inflammation with an area under the curve of 0.781, sensitivity of 60.0% and specificity of 86.4% (ADC with a b value of 500 s/mm2, 1.54 x 10(-3) mm2/s or less). CONCLUSION:The DWI measurement of hepatic ADC can be used to quantify liver fibrosis and inflammation. It will be a new approach for early diagnosis and therapeutic follow-up of hepatic fibrosis.

Quantitative study in apparent diffusion coefficients evaluate the diffusion-weighted MR imaging for clinical follow-up of liver cancer

Application of 3.0T-MRI DWI in evaluating the efficacy of synchronous radiotherapy and chemotherapy for advanced lung cancer

Diffusion-weighted MR imaging for liver cancer follow-up after transcatheter arterial chemoembolization

Diffusion Weighted Imaging and Apparent Diffusion Coefficient Value in Differential Diagnosis of Lymph Node Lesions

The Application of Diffusion-Weighted MR Imaging in Cervical Lymph Node Lesions

Clinical Application of Diffusion Weighted MR Imaging in Follow-Up of Patients Receiving Transcatheter Arterial Chemoembolization for Liver Cancer

The clinical value of MR diffusion-weighted imaging in the follow-up observation of hepatocellular carcinoma after transcatheter arterial chemoembolization

The Value of Diffusion-weighted Imagesin Diagnosis of Liver Masses

Diffusion-weighted Imaging and Variable Flip Angle T1 Mapping: a Supplement for Image-Guided Biopsy in Follow-Up Analysis of Liver Fibrosis

Diffusion-weighted MR Imaging: Characteristic Study on Tissue Component in Percutaneous Ablative Foci of the Liver

Applications of MR Diffusion-Weighted Imaging in Occupying Hepatic Lesions

Application of apparent diffusion coefficient for predicting response of hepatic metastases to chemotherapy

Comparative Study on Clinical and Pathological Changes of Liver Fibrosis with Diffusion-Weighted Imaging

Clinic Value of Diffusion Weighted and Perfusion Weighted MR Imaging in Focal Hepatic Lesions

Magnetic Resonance Imaging of Liver Tumor Dispersion Weighted Disease Diagnosis Value

Clinical application value of diffusion-weighted imaging in the diagnosis of focal space-occupying lesions in liver

Utility of diffusion weighted imaging with the quantitative apparent diffusion coefficient in diagnosing residual or recurrent hepatocellular carcinoma after transarterial chemoembolization: a meta-analysis

Clinical Study of Diffusion Weighted Imaging in Brain Tumors and Peri-tumoral Region

Utility of diffusion-weighted imaging to assess hepatocellular carcinoma viability following transarterial chemoembolization.

Application of Diffusion Weighted MR in Detecting Viable Hepatic Tumor in Ablative Therapy

The value of quantized diffussion-weighted imaging in differential diagnosis of focal liver lesions